Product
NKR-2
1 clinical trial
1 indication
Indication
Colorectal Cancer with Liver MetastasisClinical trial
An Open-label Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal CancerStatus: Terminated, Estimated PCD: 2018-01-15